Skip to content
★ Sign in to follow
김

김영선

Directeur
동국생명과학동국생명과학
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€19k
▼ Sales (0 ops.)
—

Latest filing published 02 Jul 2026 for 동국생명과학.

Filing timeline

BuySale
김영선

Insider track record

Disclosed buys
2
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

김영선: trading record in brief

김영선 (senior executive) discloses dealings in 동국생명과학 to DART (FSS). In total, 2 filings cover trades dated from 8 April 2026 to 2 July 2026.

Every open-market trade on record is a purchase: 2 purchases worth €19k, and no sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 2 July 2026: an open-market purchase, in 동국생명과학. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Companies and markets linked to 김영선

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total

2 of 2 declarations